Dow Jones

39,512.84

0.32%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

BLU

BELLUS Health (BLU)

BELLUS Health Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BLU

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
30/01/2024	09:56	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BLU	BELLUS Health Inc
14/08/2023	16:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BLU	BELLUS Health Inc
10/07/2023	07:00	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:BLU	BELLUS Health Inc
28/06/2023	16:22	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:BLU	BELLUS Health Inc
28/06/2023	16:21	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLU	BELLUS Health Inc
28/06/2023	15:11	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:BLU	BELLUS Health Inc
28/06/2023	15:10	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:BLU	BELLUS Health Inc
28/06/2023	13:42	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLU	BELLUS Health Inc
28/06/2023	10:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:BLU	BELLUS Health Inc
28/06/2023	09:59	PR Newswire (Canada)	Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS Santé	NASDAQ:BLU	BELLUS Health Inc
28/06/2023	09:57	PR Newswire (Canada)	Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health	NASDAQ:BLU	BELLUS Health Inc
16/06/2023	12:50	Business Wire	BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders	NASDAQ:BLU	BELLUS Health Inc
16/06/2023	12:50	Business Wire	BELLUS Santé inc. annonce les résultats du vote tenu à l’assemblée extraordinaire des actionnaires	NASDAQ:BLU	BELLUS Health Inc
16/05/2023	16:01	Business Wire	BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition	NASDAQ:BLU	BELLUS Health Inc
16/05/2023	16:01	Business Wire	BELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSK	NASDAQ:BLU	BELLUS Health Inc
12/05/2023	15:01	Business Wire	BELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023	NASDAQ:BLU	BELLUS Health Inc
12/05/2023	15:01	Business Wire	BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights	NASDAQ:BLU	BELLUS Health Inc
26/04/2023	17:00	Business Wire	BELLUS Health Announces Meeting Updates	NASDAQ:BLU	BELLUS Health Inc
26/04/2023	17:00	Business Wire	BELLUS Santé annonce de l’information récente au sujet de l’assemblée	NASDAQ:BLU	BELLUS Health Inc
18/04/2023	11:11	Business Wire	GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health	NASDAQ:BLU	BELLUS Health Inc
18/04/2023	09:42	Dow Jones News	Bellus Health Toronto-Listed Shares Double on GSK Takeover	NASDAQ:BLU	BELLUS Health Inc
18/04/2023	05:30	Dow Jones News	Trending: GSK Buys Bellus Health for About $2 Billion	NASDAQ:BLU	BELLUS Health Inc
18/04/2023	05:24	Dow Jones News	Bellus Health Shares Soar Premarket on Takeover by GSK	NASDAQ:BLU	BELLUS Health Inc
05/04/2023	06:00	Business Wire	BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation	NASDAQ:BLU	BELLUS Health Inc
05/04/2023	06:00	Business Wire	BELLUS Santé annonce les résultats positifs de son étude d’équivalence de la biodisponibilité de phase 1 comparant la formule à libération prolongée et à dose quotidienne unique du camlipixant avec la formule à libération immédiate...	NASDAQ:BLU	BELLUS Health Inc
30/03/2023	15:06	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BLU	BELLUS Health Inc
23/03/2023	15:49	Edgar (US Regulatory)	Annual Report (foreign Private Issuer) (40-f)	NASDAQ:BLU	BELLUS Health Inc
21/03/2023	15:30	Business Wire	BELLUS Health Reports Year 2022 Financial Results and Business Highlights	NASDAQ:BLU	BELLUS Health Inc
21/03/2023	15:30	Business Wire	BELLUS Santé annonce ses résultats financiers et faits saillants pour l’exercice 2022	NASDAQ:BLU	BELLUS Health Inc
01/03/2023	06:00	Business Wire	BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference	NASDAQ:BLU	BELLUS Health Inc